| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.10.24 | Celldex Therapeutics' Barzolvolimab Meets Phase 2 Study Endpoints For Chronic Inducible Urticaria | 704 | AFX News | WASHINGTON (dpa-AFX) - Celldex Therapeutics Inc. (CLDX) announced that barzolvolimab met all primary and secondary endpoints with high statistical significance in a positive Phase 2 study targeting... ► Artikel lesen | |
| 27.10.24 | Novartis Announces Promising 12-Month Results For Fabhalta In C3 Glomerulopathy | 873 | AFX News | BASEL (dpa-AFX) - Novartis (NVS) presented 12-month data from the Phase III APPEAR-C3G study at the American Society of Nephrology or ASN Kidney Week 2024. The results showed that patients with... ► Artikel lesen | |
| 27.10.24 | Biogen's Phase 2 Study Shows Promising Results For Felzartamab In IgA Nephropathy | 744 | AFX News | WESTON (dpa-AFX) - Biogen Inc. (BIIB) announced that results from the Phase 2 IGNAZ study evaluating felzartamab, an investigational anti-CD38 monoclonal antibody, in individuals with IgA nephropathy... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 600 |
| EVOTEC | 334 |
| NOVO NORDISK | 323 |
| TESLA | 290 |
| RHEINMETALL | 246 |
| BYD | 233 |
| RENK GROUP | 169 |
| DEUTZ | 161 |
| TUI | 135 |
| APPLE | 132 |
| BASF | 132 |
| VOLKSWAGEN | 130 |
| NETFLIX | 127 |
| STEYR MOTORS | 127 |
| BAYER | 124 |
| PLUG POWER | 120 |
| AMAZON | 117 |
| ALMONTY | 113 |
| UNITEDHEALTH | 113 |
| XIAOMI | 108 |
| COMMERZBANK | 106 |
| E.ON | 105 |
| NEL | 105 |
| RWE | 105 |
| SIEMENS ENERGY | 100 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
